Next Article in Journal
Patient- and Surgery-Related Factors that Affect Patient-Reported Outcomes after Total Hip Arthroplasty
Next Article in Special Issue
Biobanking Organoids or Ground-State Stem Cells?
Previous Article in Journal
Drug-Induced Interstitial Lung Disease: A Systematic Review
Previous Article in Special Issue
Biobanking and Regenerative Medicine: An Overview
Open AccessReview

NANOmetric BIO-Banked MSC-Derived Exosome (NANOBIOME) as a Novel Approach to Regenerative Medicine

Tecnologica Research Institute, 88900 Crotone, Italy
Marrelli Health, 88900 Crotone, Italy
Author to whom correspondence should be addressed.
J. Clin. Med. 2018, 7(10), 357;
Received: 3 September 2018 / Revised: 28 September 2018 / Accepted: 12 October 2018 / Published: 15 October 2018
(This article belongs to the Special Issue Biobanking and Regenerative Medicine)
Mesenchymal stem cells (MSCs) are well known for their great potential in clinical applications. In fact, MSCs can differentiate into several cell lineages and show paracrine behavior by releasing endogenous factors that stimulate tissue repair and modulate local immune response. Each MSC type is affected by specific biobanking issues—technical issues as well as regulatory and ethical concerns—thus making it quite tricky to safely and commonly use MSC banking for swift regenerative applications. Extracellular vesicles (EVs) include a group of 150–1000 nm vesicles that are released by budding from the plasma membrane into biological fluids and/or in the culture medium from varied and heterogenic cell types. EVs consist of various vesicle types that are defined with different nomenclature such as exosomes, shedding vesicles, nanoparticles, microvesicles and apoptotic bodies. Ectosomes, micro- and nanoparticles generally refer to the direct release of single vesicles from the plasma membrane. While many studies describe exosomes as deriving from multivesicular bodies, solid evidence about the origin of EVs is often lacking. Extracellular vesicles represent an important portion of the cell secretome. Their numerous properties can be used for diagnostic, prognostic, and therapeutic uses, so EVs are considered to be innovative and smart theranostic tools. The aim of this review is to investigate the usefulness of exosomes as carriers of the whole information panel characterizing the use of MSCs in regenerative medicine. Our purpose is to make a step forward in the development of the NANOmetric BIO-banked MSC-derived Exosome (NANOBIOME). View Full-Text
Keywords: MSCs; EVs; exosomes; tissue regeneration; immunomodulation; biobanking MSCs; EVs; exosomes; tissue regeneration; immunomodulation; biobanking
Show Figures

Figure 1

MDPI and ACS Style

Codispoti, B.; Marrelli, M.; Paduano, F.; Tatullo, M. NANOmetric BIO-Banked MSC-Derived Exosome (NANOBIOME) as a Novel Approach to Regenerative Medicine. J. Clin. Med. 2018, 7, 357.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop